PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
93.60
-0.85 (-0.90%)
Nov 22, 2024, 4:00 PM EST - Market closed

Company Description

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally.

The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH).

It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH.

PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

PROCEPT BioRobotics Corporation
PROCEPT BioRobotics logo
Country United States
Founded 2009
IPO Date Sep 15, 2021
Industry Medical Devices
Sector Healthcare
Employees 626
CEO Reza Zadno

Contact Details

Address:
150 Baytech Drive
San Jose, California 95134
United States
Phone 650 232 7200
Website procept-biorobotics.com

Stock Details

Ticker Symbol PRCT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $25.00
CIK Code 0001588978
CUSIP Number 74276L105
ISIN Number US74276L1052
Employer ID 26-0199180
SIC Code 3841

Key Executives

Name Position
Dr. Reza Zadno Ph.D. President, Chief Executive Officer and Director
Kevin Waters Executive Vice President and Chief Financial Officer
Alaleh Nouri EVice President, Chief Legal Officer and Corporate Secretary
Hisham Shiblaq Executive Vice President and Chief Commercial Officer
Mohan F. Sancheti Senior Vice President of Operations
Barry Templin Executive Vice President of Technology and Clinical Development
Matthew James Bacso C.F.A. Vice President of Investor Relations
Stacey L. Porter Chief People Officer
Bijesh Chandran Senior Vice President of Regulatory Affairs and Quality Assurance

Latest SEC Filings

Date Type Title
Nov 20, 2024 144 Filing
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 13, 2024 144 Filing
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 5, 2024 144 Filing
Nov 4, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Oct 31, 2024 8-K Current Report
Oct 30, 2024 424B5 Filing
Oct 28, 2024 424B5 Filing
Oct 28, 2024 10-Q Quarterly Report